Johnson & Johnson is selling its remaining Kenvue shares
By Ciara Linnane
Company plans debt-for-equity exchange with Goldman Sachs and J.P. Morgan, followed by a secondary offering of 182.3 million Kenvue shares
Johnson & Johnson is selling its remaining shares in Kenvue Inc., the consumer-health business that it spun out last year.
The company will exchange the 182.3 million shares of Kenvue's common stock it still owns for Johnson & Johnson debt held by Goldman Sachs and J.P. Morgan, Kenvue said in a statement on Monday.
The shares will then be offered to the public in a deal underwritten by Goldman, J.P. Morgan and BofA Securities.
Kenvue (KVUE) will not receive any proceeds from the sale or from the debt-for-equity exchange. Once the debt-for-equity exchange is complete, the selling shareholders will sell the shares to the underwriters of the offering. Johnson & Johnson (JNJ) will no longer own any Kenvue shares once the deal is completed.
The news comes about a week after Kenvue reported first-quarter earnings that exceeded expectations and said it would cut about 4% of its global workforce.
The company entered a transition service agreement with Johnson & Johnson in 2023 under which it will provide services to the company for varying periods of time.
It has now launched a program to better position itself for growth that involves reducing pretax costs by about $350 million.
For more, read: Kenvue's stock jumps after earnings beat as company unveils plan to cut 4% of global workforce
The stock was up 0.6% Monday but has fallen 4% in the year to date, while the S&P 500 SPX has gained 9.5%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-13-24 1017ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
13 Charts On the Market’s Q2 Turnaround
-
10 Top-Performing Dividend Stocks of Q2 2024
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations
-
Real Estate: Interest Rate Movements Drive Performance
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities